Brief: Bavarian Nordic Receives U.S. FDA Approval Of Freeze-Dried Smallpox And Mpox Vaccine
31/03/2025 21:39
March 31 (Reuters) - Bavarian Nordic A/S BAVA.CO: BAVARIAN NORDIC RECEIVES U.S. FDA APPROVAL OF FREEZE-DRIED SMALLPOX AND MPOX VACCINE BAVARIAN NORDIC A/S - FIRST FREEZE-DRIED JYNNEOS VACCINES TO BE DELIVERED IN 2025 BAVARIAN NORDIC A/S - CONTRACTED BY BARDA TO DEVELOP FREEZE-DRIED JYNNEOS FOR STOCKPILING Source text: ID:nGNE50pmbT Further company coverage: BAVA.CO ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Bavarian Nordic A/S
See all newsBrief: Bavarian Nordic Gets Smallpox/Mpox Vaccine Supply Contract
Brief: Bavarian Nordic Secures Additional Government Contract For The Supply Of Smallpox/Mpox Vaccine
Brief: Bavarian Nordic Launches Final Tranche Of Buy-Back Program
Bavarian Nordic falls as high costs, lower vaccine sales hit Q1 results
Bavarian Nordic Q1 revenue falls as Public Preparedness unit sales decline